Back to ROYAL BANK OF CANADA ROYAL BANK OF CANADA

RNAMRNAM
Showing 7 of 22 quarters

Position history for ROYAL BANK OF CANADAROYAL BANK OF CANADA's holdings in <![CDATA[AVIDITY BIOSCIENCES INC]]>

As of its Q4 2025 13F, Royal Bank of Canada held 5,131 shares of RNAM (<![cdata[avidity Biosciences Inc]]>), worth $369,000. Royal Bank of Canada's 13F filings listed RNAM from Q4 2020 to Q4 2025, 21 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.4M

Total Shares Change

-51,582

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q4
Decreased
5,131
-98.4%
$369,0000.0%—
0
2025-Q3
Decreased
316,459
-47.8%
$13.8M0.0%—
0
2025-Q2
Increased
606,707
+1269.4%
$17.2M0.0%—
46
2025-Q1
Increased
44,304
+38.2%
$1.3M0.0%—
33
2024-Q4
Decreased
32,063
-37.8%
$932,0000.0%—
0
2024-Q3
Increased
51,582
+410.3%
$2.4M0.0%—
42

Other major holders of RNAM: VANGUARD GROUP INC, FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used